Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sex-Related Differences in Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Veselka J, Faber L, Liebregts M, Cooper R, Kashtanov M, Hansen PR, Bonaventura J, Polakova E, Hansvenclova E, Bundgaard H, Ten Berg J, Jensen MK. Veselka J, et al. Among authors: hansvenclova e. JACC Cardiovasc Interv. 2021 Jun 28;14(12):1390-1392. doi: 10.1016/j.jcin.2021.03.066. JACC Cardiovasc Interv. 2021. PMID: 34167687 Free article. No abstract available.
Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.
Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Stables RH, Jensen MK. Veselka J, et al. Among authors: hansvenclova e. Eur Heart J. 2019 Jun 1;40(21):1681-1687. doi: 10.1093/eurheartj/ehz110. Eur Heart J. 2019. PMID: 31152553
Alcohol septal ablation in patients with severe septal hypertrophy.
Veselka J, Jensen M, Liebregts M, Cooper RM, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Hilton Stables R, Faber L. Veselka J, et al. Among authors: hansvenclova e. Heart. 2020 Mar;106(6):462-466. doi: 10.1136/heartjnl-2019-315422. Epub 2019 Aug 30. Heart. 2020. PMID: 31471463
Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry.
Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Dabrowski M, Hansen PR, Seggewiss H, Horstkotte D, Hansvenclova E, Bundgaard H, Ten Berg J, Jensen MK. Veselka J, et al. Among authors: hansvenclova e. Arch Med Sci. 2020 Aug 10;16(5):1239-1242. doi: 10.5114/aoms.2020.97969. eCollection 2020. Arch Med Sci. 2020. PMID: 32864015 Free PMC article. No abstract available.
Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy.
Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Bonaventura J, Polakova E, Hansvenclova E, Bundgaard H, Ten Berg J, Stables RH, Jarkovsky J, Jensen MK. Veselka J, et al. Among authors: hansvenclova e. Int J Cardiol. 2021 Jun 15;333:127-132. doi: 10.1016/j.ijcard.2021.02.056. Epub 2021 Feb 27. Int J Cardiol. 2021. PMID: 33647367 Free article.
Mid-term outcomes of patients with Lotus and Evolut transcatheter valves.
Hájek P, Polaková E, Adlová R, Horváth M, Hansvenclová E, Pecková M, Veselka J. Hájek P, et al. Among authors: hansvenclova e. Postepy Kardiol Interwencyjnej. 2022 Jun;18(2):146-153. doi: 10.5114/aic.2022.118531. Epub 2022 Aug 19. Postepy Kardiol Interwencyjnej. 2022. PMID: 36051828 Free PMC article.
Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.
Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Kashtanov M, Tesarkova KH, Hansen PR, Seggewiss H, Shloydo E, Popov K, Hansvenclova E, Polakova E, Ten Berg J, Stables RH, Jarkovsky J, Bonaventura J. Veselka J, et al. Among authors: hansvenclova e. Am J Cardiol. 2022 Dec 1;184:120-126. doi: 10.1016/j.amjcard.2022.08.028. Epub 2022 Oct 1. Am J Cardiol. 2022. PMID: 36192196
Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation.
Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Kashtanov M, Tesarkova KH, Hansen PR, Seggewiss H, Shloydo E, Popov K, Hansvenclova E, Bonaventura J, Berg JT, Stables RH, Polakova E. Veselka J, et al. Among authors: hansvenclova e. JACC Cardiovasc Interv. 2022 Oct 10;15(19):1910-1917. doi: 10.1016/j.jcin.2022.06.034. Epub 2022 Sep 14. JACC Cardiovasc Interv. 2022. PMID: 36202559 Free article.
Outcomes of Alcohol Septal Ablation in Patients With Severe Left Ventricular Outflow Tract Obstruction: A Propensity Score Matching Analysis.
Veselka J, Liebregts M, Cooper R, Faber L, Januska J, Tesarkova KH, Hansen PR, Seggewiss H, Hansvenclova E, Bonaventura J, Vejtasova V, Ten Berg J, Stables RH, Jensovsky M. Veselka J, et al. Among authors: hansvenclova e. Can J Cardiol. 2023 Nov;39(11):1622-1629. doi: 10.1016/j.cjca.2023.06.417. Epub 2023 Jun 22. Can J Cardiol. 2023. PMID: 37355228
16 results